State Street Corp Pulse Biosciences, Inc. Transaction History

State Street Corp

  • $2.59 Trillion
  • Q2 2025

A detailed history of State Street Corp transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, State Street Corp holds 419,256 shares of PLSE stock, worth $6.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
419,256
Previous 419,244 -0.0%
Holding current value
$6.33 Million
Previous $6.75 Million 6.21%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$14.48 - $19.27 $173 - $231
12 Added 0.0%
419,256 $6.33 Million
Q1 2025

May 15, 2025
SELL
$15.61 - $24.56 $858,643 - $1.35 Million
-55,006 Reduced 11.6%
419,244 $6.75 Million
Q4 2024

Feb 14, 2025
BUY
$14.56 - $21.08 $188,071 - $272,290
12,917 Added 2.8%
474,250 $8.76 Million
Q3 2024

Nov 14, 2024
BUY
$10.83 - $21.83 $754,807 - $1.52 Million
69,696 Added 17.8%
461,333 $8.09 Million
Q2 2024

Aug 14, 2024
BUY
$6.69 - $14.54 $280,290 - $609,182
41,897 Added 11.98%
391,637 $4.38 Million
Q1 2024

May 15, 2024
BUY
$7.8 - $11.02 $313,716 - $443,224
40,220 Added 12.99%
349,740 $3.05 Million
Q4 2023

Feb 14, 2024
BUY
$3.85 - $12.84 $97,343 - $324,646
25,284 Added 8.9%
309,520 $3.79 Million
Q3 2023

Nov 14, 2023
SELL
$4.03 - $8.73 $1,607 - $3,483
-399 Reduced 0.14%
284,236 $1.15 Million
Q2 2023

Aug 14, 2023
BUY
$3.67 - $8.64 $794,679 - $1.87 Million
216,534 Added 317.96%
284,635 $2.05 Million
Q4 2022

Feb 14, 2023
BUY
$1.73 - $2.89 $30,102 - $50,286
17,400 Added 34.32%
68,101 $188,000
Q2 2022

Aug 15, 2022
SELL
$1.48 - $4.28 $286,415 - $828,282
-193,524 Reduced 79.24%
50,701 $78,000
Q1 2022

May 16, 2022
BUY
$4.21 - $14.79 $9,725 - $34,164
2,310 Added 0.95%
244,225 $1.19 Million
Q4 2021

Feb 14, 2022
SELL
$14.78 - $24.4 $26,766 - $44,188
-1,811 Reduced 0.74%
241,915 $3.58 Million
Q3 2021

Nov 15, 2021
BUY
$17.25 - $26.63 $1,845 - $2,849
107 Added 0.04%
243,726 $5.26 Million
Q2 2021

Aug 16, 2021
BUY
$16.31 - $23.64 $229,155 - $332,142
14,050 Added 6.12%
243,619 $4 Million
Q1 2021

May 17, 2021
SELL
$22.43 - $44.27 $8,949 - $17,663
-399 Reduced 0.17%
229,569 $5.44 Million
Q4 2020

Feb 16, 2021
BUY
$11.66 - $24.5 $3,579 - $7,521
307 Added 0.13%
229,968 $5.49 Million
Q3 2020

Nov 10, 2020
SELL
$9.27 - $13.14 $15,527 - $22,009
-1,675 Reduced 0.72%
229,661 $2.71 Million
Q2 2020

Aug 14, 2020
BUY
$6.23 - $13.09 $258,682 - $543,522
41,522 Added 21.88%
231,336 $2.42 Million
Q1 2020

May 11, 2020
BUY
$5.23 - $15.2 $992,727 - $2.89 Million
189,814 New
189,814 $1.36 Million

Others Institutions Holding PLSE

# of Institutions
90
Shares Held
5.86M
Call Options Held
37.5K
Put Options Held
33.6K
View Full List

About Pulse Biosciences, Inc.

PLSE Quotes by TradingView
  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $561M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email